The impact of genetic polymorphisms in risk assessment of drugs.
Poulsen
H E
HE
Department of Pharmacology, University of Copenhagen, Panum Institute, Denmark.
Loft
S
S
D001191:Arylamine N-Acetyltransferase / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D064420:Drug-Related Side Effects and Adverse Reactions; D005838:Genotype; D006801:Humans; D008099:Liver / Q000201:enzymology; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010641:Phenotype; D011110:Polymorphism, Genetic / Q000502:physiology*; D012307:Risk Factors
D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System; D001191:Arylamine N-Acetyltransferase